Literature DB >> 14697333

Phenobarbital responsiveness as a uniquely sensitive indicator of hepatocyte differentiation status: requirement of dexamethasone and extracellular matrix in establishing the functional integrity of cultured primary rat hepatocytes.

Jaspreet S Sidhu1, Fei Liu, Curtis J Omiecinski.   

Abstract

We used a serum-free, highly defined primary hepatocyte culture model to investigate the mechanisms whereby dexamethasone (Dex) and extracellular matrix (ECM) coordinate cell differentiation and transcriptional responsiveness to the inducer, phenobarbital (PB). Low nanomolar levels of Dex and dilute concentrations of ECM overlay were essential in the maintenance of normal hepatocyte physiology, as assessed by cell morphology, LDH release, expression of the hepatic nuclear factors C/EBPalpha, -beta, -gamma, HNF-1alpha, -1beta, -4alpha, and RXRalpha, expression of prototypical hepatic marker genes, including albumin and transferrin, and ultimately, cellular capacity to respond to PB. The loss of hepatocyte integrity produced by deficiency of these components correlated with the activation of several stress signaling pathways including the MAPK, SAPK/JNK, and c-Jun signaling pathways, with resulting nuclear recruitment of the activated protein-1 (AP-1) complex. In Dex-deficient cultures, normal cellular function, including the PB induction response, was largely restored in a dose-dependent manner by reintroduction of nanomolar additions of the hormone, in the presence of ECM. Our results demonstrate critical and cooperative roles for Dex and ECM in establishing hepatocyte integrity and in the coordination of an array of liver-specific functions. These studies further establish the PB gene induction response as an exceptionally sensitive indicator of hepatocyte differentiation status.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14697333     DOI: 10.1016/j.yexcr.2003.09.001

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  18 in total

1.  De-differentiation of primary human hepatocytes depends on the composition of specialized liver basement membrane.

Authors:  Michael Zeisberg; Kyle Kramer; Nazia Sindhi; Pradip Sarkar; Melissa Upton; Raghu Kalluri
Journal:  Mol Cell Biochem       Date:  2006-02       Impact factor: 3.396

2.  Gene expression profiling of extracellular matrix as an effector of human hepatocyte phenotype in primary cell culture.

Authors:  Jeanine L Page; Mary C Johnson; Katy M Olsavsky; Steven C Strom; Helmut Zarbl; Curtis J Omiecinski
Journal:  Toxicol Sci       Date:  2007-02-27       Impact factor: 4.849

3.  Cell shape regulates global histone acetylation in human mammary epithelial cells.

Authors:  Johanne Le Beyec; Ren Xu; Sun-Young Lee; Celeste M Nelson; Aylin Rizki; Jordi Alcaraz; Mina J Bissell
Journal:  Exp Cell Res       Date:  2007-04-27       Impact factor: 3.905

Review 4.  The conduct of drug metabolism studies considered good practice (II): in vitro experiments.

Authors:  Lee Jia; Xiaodong Liu
Journal:  Curr Drug Metab       Date:  2007-12       Impact factor: 3.731

5.  Preservation of hepatic phenotype in lentiviral-transduced primary human hepatocytes.

Authors:  Stephanie M Zamule; Stephen C Strom; Curtis J Omiecinski
Journal:  Chem Biol Interact       Date:  2008-04-08       Impact factor: 5.192

6.  Multi-species analyses of direct activators of the constitutive androstane receptor.

Authors:  Curtis J Omiecinski; Denise M Coslo; Tao Chen; Elizabeth M Laurenzana; Richard C Peffer
Journal:  Toxicol Sci       Date:  2011-07-21       Impact factor: 4.849

7.  Aryl-hydrocarbon receptor activation regulates constitutive androstane receptor levels in murine and human liver.

Authors:  Rushang D Patel; Brett D Hollingshead; Curtis J Omiecinski; Gary H Perdew
Journal:  Hepatology       Date:  2007-07       Impact factor: 17.425

8.  Gene expression profiling and differentiation assessment in primary human hepatocyte cultures, established hepatoma cell lines, and human liver tissues.

Authors:  Katy M Olsavsky; Jeanine L Page; Mary C Johnson; Helmut Zarbl; Stephen C Strom; Curtis J Omiecinski
Journal:  Toxicol Appl Pharmacol       Date:  2007-04-21       Impact factor: 4.219

9.  Amniotic mesenchymal stem cells derived hepatocyte-like cells attenuated liver fibrosis more efficiently by mixed-cell transplantation.

Authors:  Hui Wang; Yuan Tian; Xin Li; Meijia Yang; Ying Yan
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2020-02-25

Review 10.  Generating hepatic cell lineages from pluripotent stem cells for drug toxicity screening.

Authors:  Melissa A Baxter; Cliff Rowe; Jane Alder; Sean Harrison; Karen Piper Hanley; B Kevin Park; Neil R Kitteringham; Chris E Goldring; Neil A Hanley
Journal:  Stem Cell Res       Date:  2010-03-04       Impact factor: 2.020

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.